These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2886290)

  • 1. Peptic erosion of gastric mucus in the rat.
    Munster DJ; Bagshaw PF; Wilson JG
    Comp Biochem Physiol A Comp Physiol; 1987; 87(2):509-13. PubMed ID: 2886290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucus degradation by pepsin: comparison of mucolytic activity of human pepsin 1 and pepsin 3: implications in peptic ulceration.
    Pearson JP; Ward R; Allen A; Roberts NB; Taylor WH
    Gut; 1986 Mar; 27(3):243-8. PubMed ID: 3084340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inhibition of peptic degradation of porcine gastric mucus glycoprotein by sucralfate.
    Slomiany BL; Laszewicz W; Slomiany A
    Scand J Gastroenterol; 1985 Sep; 20(7):857-60. PubMed ID: 3931205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ethanol on the peptic degradation of gastric mucus glycoprotein.
    Laszewicz W; Slomiany A; Murty VL; Liau YH; Slomiany BL
    Digestion; 1985; 31(1):47-53. PubMed ID: 3920096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucus, pepsin, and peptic ulcer.
    Venables CW
    Gut; 1986 Mar; 27(3):233-8. PubMed ID: 3084339
    [No Abstract]   [Full Text] [Related]  

  • 6. Gastric mucus: isolation and polymeric structure of the undegraded glycoprotein: its breakdown by pepsin.
    Pearson J; Allen A; Venables C
    Gastroenterology; 1980 Apr; 78(4):709-15. PubMed ID: 6766422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ecabet sodium, a novel locally-acting anti-ulcer agent, protects the integrity of the gastric mucosal gel layer from pepsin-induced disruption in the rat.
    Kinoshita M; Endo M; Yasoshima A; Saito N; Yamasaki K; Chishima S; Narita H
    Aliment Pharmacol Ther; 1999 May; 13(5):687-94. PubMed ID: 10233194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gastroduodenal mucus barrier and its role in protection against luminal pepsins: the effect of 16,16 dimethyl prostaglandin E2, carbopol-polyacrylate, sucralfate and bismuth subsalicylate.
    Copeman M; Matuz J; Leonard AJ; Pearson JP; Dettmar PW; Allen A
    J Gastroenterol Hepatol; 1994; 9 Suppl 1():S55-9. PubMed ID: 7881020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherent and soluble mucus in the stomach and duodenum.
    Allen A; Carroll NJ
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):55S-62S. PubMed ID: 3932055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric mucus degradation in vivo in peptic ulcer patients and the effects of vagotomy.
    Younan F; Pearson JP; Allen A; Venables CW
    Adv Exp Med Biol; 1982; 144():235-7. PubMed ID: 7044060
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of subdiaphragmatic vagotomy on the gastric mucus barrier in rats.
    Somasundaram K; Ganguly AK
    Clin Exp Pharmacol Physiol; 1987 Sep; 14(9):735-41. PubMed ID: 3442955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin protection against ethanol-induced gastric injury: regulatory effect on the mucus glycoprotein metabolism.
    Tsukada H; Zielenski J; Mizuta K; Slomiany BL; Slomiany A
    Digestion; 1987; 36(4):201-12. PubMed ID: 3111916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pepsin hydrolysis of the adherent mucus barrier and subsequent gastric mucosal damage in the rat: effect of diosmectite and 16,16 dimethyl prostaglandin E2.
    Leonard A; Droy-Lefaix MT; Allen A
    Gastroenterol Clin Biol; 1994; 18(6-7):609-16. PubMed ID: 7533109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing action of teprenone, a new antiulcer agent, on high-molecular-weight glycoprotein in gastric mucus during the healing process of acetic acid-induced ulcer in rats.
    Ito M; Tanaka T; Suzuki Y
    Jpn J Pharmacol; 1986 May; 41(1):117-25. PubMed ID: 3755480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the structure of the mucous gel on the mucosal surface of the stomach in association with peptic ulcer disease.
    Younan F; Pearson J; Allen A; Venables C
    Gastroenterology; 1982 May; 82(5 Pt 1):827-31. PubMed ID: 7060905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pepsin and the gastric mucus barrier.
    Sidebotham RL; Batten JJ; Dhir NK; Baron JH
    Dig Dis Sci; 1990 Oct; 35(10):1305-7. PubMed ID: 2209297
    [No Abstract]   [Full Text] [Related]  

  • 17. Pepsins and the mucus barrier in peptic ulcer disease.
    Allen A; Pearson JP; Blackburn A; Coan RM; Hutton DA; Mall AS
    Scand J Gastroenterol Suppl; 1988; 146():50-7. PubMed ID: 3147508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of mucus glycoprotein erosion by measurement of sialic acid in gastric secretions: pathophysiologic and therapeutic aspects.
    Pasquier MC; Vatier J; Poitevin C; Vallot T; Mignon M
    J Clin Gastroenterol; 1991; 13 Suppl 1():S22-31. PubMed ID: 1940193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some effects of tripotassium dicitrato bismuthate on gastric secretion and the mucus barrier.
    Sidebotham RL; Batten JJ; Li K; Spencer J; Baron JH
    Aliment Pharmacol Ther; 1990 Oct; 4(5):535-46. PubMed ID: 2129641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucus glycoprotein structure, gel formation and gastrointestinal mucus function.
    Allen A; Hutton DA; Pearson JP; Sellers LA
    Ciba Found Symp; 1984; 109():137-56. PubMed ID: 6394242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.